Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Table 2 Clinical outcomes of the three types of laparoscopic reoperation
Characteristic
Reoperative laparoscopic left lateral sectionectomy (n = 40)
Reoperative laparoscopic left hemihepatectomy (n = 50)
Reoperative laparoscopic complex hepatectomy (n = 11)
χ²/H value
P value
Selective hepatic blood flow occlusion8/40 (20.0)47/50 (94.0)67/11 (63.6)6,751.364< 0.0011
Operation duration, median (IQR), minute240.0 (196.3-322.5)325.0 (254.5-387.8)6350.0 (295.0-460.0)614.5080.0012
Blood loss, median (IQR), mL200.0 (75.0-281.2)200.0 (100.0-400.0)400.0 (200.0-800.0)5.8370.0542
Blood transfusion4/40 (10.0)11/50 (22.0)66/11 (54.5)610.4830.0051
Conversion to open surgery3/40 (7.5)8/50 (16.0)4/11 (36.4)65.7870.0551
Postoperative intensive care unit stay5/40 (12.5)10/50 (20.0)7/11 (63.6)6,713.4260.0011
Postoperative stay, median (IQR), days8.0 (6.0-10.0)8.0 (7.0-12.3)10.0 (7.0-13.0)2.2110.3312
Early complications within 90 days17/40 (42.5)27/50 (54.0)7/11 (63.6)2.0280.3631
Major complications within 90 days2/40 (5.0)3/50 (6.0)0/11 (0.0)N/A31.000
Reinterventions within 90 days2/40 (5.0)3/50 (6.0)0/11 (0.0)N/A31.000
Readmission within 90 days6/40 (15.0)10/50 (20.0)3/11 (27.3)0.9420.6241
90-day mortality0/40 (0.0)0/50 (0.0)0/11 (0.0)--
Initial stone clearance433/40 (82.5)36/48 (75.0)8/11 (72.7)0.8930.6401
Re-treatment for residual stones42/40 (5.0)6/48 (12.5)1/11 (9.1)N/A30.412
Final stone clearance434/40 (85.0)39/48 (81.3)8/11 (72.7)0.8940.6401
Stone recurrence52/34 (5.9)2/39 (5.1)0/8 (0.0)N/A31.000
Late complications41/40 (2.5)3/48 (6.3)1/11 (9.1)N/A30.411
Late major complications40/40 (0.0)1/48 (2.1)0/11 (0.0)N/A31.000
Secondary ICC41/40 (2.5)0/48 (0.0)0/11 (0.0)N/A30.515
Late death due to complications or ICC41/40 (2.5)0/48 (0.0)0/11 (0.0)N/A30.515